You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Pfizer Returns vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
Pfizer Company Info
A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
News & Analysis
Pfizer's decline seems a bit premature.
Pfizer's revenue growth is far from over.
This drugmaker is among the most dominant pharmaceutical companies in the world.
The pharmaceutical company is looking for a future beyond COVID-19 therapies.
These are investments that you can buy and forget about.
The vaccine revenue was nice, but it's time to look ahead.
These two dividend stocks offer 3%-plus dividend yields that are secure.
Is Pfizer a good contrarian buy?
A look at stock market news.
Investors knew that a vaccine was coming, so why did the market react the way it did?
Some of our favorite banks and real estate stocks are having their best rallies in years.
First, it raised some spinoff speculation. Second, it's in an intriguing tussle with J&J that could affect the biosimilars market for everyone.
PFE earnings call for the period ending September 30, 2022.
PFE earnings call for the period ending June 30, 2022.
PFE earnings call for the period ending December 31, 2021.
PFE earnings call for the period ending September 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.